Association between adenomyosis volume and adverse perinatal outcomes: multicenter cohort study
- PMID: 39482801
- DOI: 10.1002/uog.29108
Association between adenomyosis volume and adverse perinatal outcomes: multicenter cohort study
Erratum in
-
Correction to 'Association between adenomyosis volume and adverse perinatal outcomes: multicenter cohort study'.Ultrasound Obstet Gynecol. 2025 Apr;65(4):512. doi: 10.1002/uog.29180. Epub 2025 Jan 18. Ultrasound Obstet Gynecol. 2025. PMID: 39825878 No abstract available.
Abstract
Objective: To assess the association between adenomyosis volume, as a reflection of its severity, and the risk of adverse perinatal outcomes.
Methods: This multicenter retrospective cohort study was conducted at a comprehensive tertiary care institution and a tertiary maternal and child healthcare hospital, which are the main types of hospital providing maternal medical care in China. The study included pregnant women without adenomyosis (non-AD cohort) who delivered between 1 January 2021 and 31 December 2021, and women with pregnancy complicated by adenomyosis (AD cohort) who delivered between 1 January 2020 and 31 December 2022. Adenomyosis was diagnosed and measured using transvaginal or transabdominal ultrasound up to 14 weeks of gestation. The adenomyosis volume (V) was calculated based on the sonographic measurement of three dimensions, using the formula V = (length × width × thickness) × 4/3π. Univariate and multivariate logistic regression analyses were conducted to assess the association between adenomyosis and the risk of pregnancy complications. We also performed a sensitivity analysis among 226 pregnancies complicated by adenomyosis that had volume measurements available and 10 507 pregnancies without adenomyosis, using as a threshold for severe adenomyosis the 3rd quartile of adenomyosis volume.
Results: The study group included 10 507 pregnant women in the non-AD cohort and 321 in the AD cohort. Pregnancies complicated by adenomyosis had an increased risk of preterm birth < 37 weeks of gestation (adjusted odds ratio (aOR), 2.39 (95% CI, 1.65-3.48)), spontaneous preterm birth < 37 weeks of gestation (aOR, 2.57 (95% CI, 1.54-4.28)), placenta previa (aOR, 2.57 (95% CI, 1.41-4.67)), cervical incompetence (aOR, 9.70 (95% CI, 4.00-23.55)) and abnormal fetal presentation (aOR, 2.04 (95% CI, 1.39-3.00)), and there was also a non-significant trend toward increased risk of pre-eclampsia (aOR, 1.64 (95% CI, 0.94-2.85)). Sensitivity analysis revealed there was a greater risk in pregnancies with severe (≥ 757.5 cm3) vs mild adenomyosis of preterm birth < 37 weeks of gestation (aOR, 5.50 (95% CI, 2.80-10.82) vs aOR, 1.73 (95% CI, 0.98-3.05)), pre-eclampsia (aOR, 4.94 (95% CI, 2.11-11.58) vs aOR, 1.03 (95% CI, 0.41-2.58)), placenta previa (aOR, 6.37 (95% CI, 2.39-17.04) vs aOR, 1.58 (95% CI, 0.60-4.19)) and cervical incompetence (aOR, 12.79 (95% CI, 2.87-56.93) vs aOR, 4.97 (95% CI, 1.25-19.77)) compared to pregnancies without adenomyosis. The risk of spontaneous preterm birth < 37 weeks and the risk of abnormal fetal presentation was similar between the two subgroups.
Conclusion: Pregnancies complicated by adenomyosis, particularly those with severe adenomyosis, have an increased risk of pregnancy complications, including preterm birth, spontaneous preterm birth, placenta previa, cervical incompetence and abnormal fetal presentation. © 2024 International Society of Ultrasound in Obstetrics and Gynecology.
Keywords: abnormal fetal presentation; adenomyosis; cervical incompetence; placenta previa; preterm birth; spontaneous preterm birth; ultrasound imaging.
© 2024 International Society of Ultrasound in Obstetrics and Gynecology.
Similar articles
-
The role of maternal age on adverse pregnancy outcomes among primiparous women with singleton birth: a retrospective cohort study in urban areas of China.J Matern Fetal Neonatal Med. 2023 Dec;36(2):2250894. doi: 10.1080/14767058.2023.2250894. J Matern Fetal Neonatal Med. 2023. PMID: 37635092
-
The association between uterine adenomyosis and adverse obstetric outcomes: A propensity score-matched analysis.Acta Obstet Gynecol Scand. 2023 Jul;102(7):833-842. doi: 10.1111/aogs.14581. Epub 2023 Apr 23. Acta Obstet Gynecol Scand. 2023. PMID: 37087741 Free PMC article.
-
Increased risk of placenta previa and preterm birth in pregnant women with endometriosis/adenomyosis: A propensity-score matching analysis of a nationwide perinatal database in Japan.J Obstet Gynaecol Res. 2024 Mar;50(3):351-357. doi: 10.1111/jog.15849. Epub 2023 Dec 10. J Obstet Gynaecol Res. 2024. PMID: 38072834
-
Untangling the independent effect of endometriosis, adenomyosis, and ART-related factors on maternal, placental, fetal, and neonatal adverse outcomes: results from a systematic review and meta-analysis.Hum Reprod Update. 2024 Dec 1;30(6):751-788. doi: 10.1093/humupd/dmae024. Hum Reprod Update. 2024. PMID: 39049473
-
IVF/ICSI treatment and the risk of iatrogenic preterm birth in singleton pregnancies: systematic review and meta-analysis of cohort studies.J Matern Fetal Neonatal Med. 2022 May;35(10):1987-1996. doi: 10.1080/14767058.2020.1771690. Epub 2020 Jun 4. J Matern Fetal Neonatal Med. 2022. PMID: 32498576
Cited by
-
Association between pre-pregnancy uterine volume and preterm birth in women with adenomyosis: a retrospective cohort study.BMC Pregnancy Childbirth. 2025 Jul 3;25(1):718. doi: 10.1186/s12884-025-07845-0. BMC Pregnancy Childbirth. 2025. PMID: 40610904 Free PMC article.
References
-
- Guo S, Li Z, Yan L, Sun Y, Feng Y. GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther. 2018;12:1621‐1631.
-
- Liu X, Shen M, Qi Q, Zhang H, Guo SW. Corroborating evidence for platelet‐induced epithelial‐mesenchymal transition and fibroblast‐to‐myofibroblast transdifferentiation in the development of adenomyosis. Hum Reprod. 2016;31(4):734‐749.
-
- Shen M, Liu X, Zhang H, Guo SW. Transforming growth factor β1 signaling coincides with epithelial‐mesenchymal transition and fibroblast‐to‐myofibroblast transdifferentiation in the development of adenomyosis in mice. Hum Reprod. 2016;31(2):355‐369.
-
- Naftalin J, Hoo W, Pateman K, Mavrelos D, Holland T, Jurkovic D. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27(12):3432‐3439.
-
- Puente JM, Fabris A, Patel J, et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol. 2016;14(1):60.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous